Mozessohn L[au] - Search Results

Year	Number of Results
2005	1
2012	2
2013	1
2014	2
2015	1
2016	1
2017	2
2018	1
2020	4
2021	4
2022	4

1

Response.

Mozessohn L, Earle CC, Spaner D, Cheng SY, Kumar M, Buckstein R. Mozessohn L, et al. J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djx027. J Natl Cancer Inst. 2017. PMID: 28423404 No abstract available.

2

Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.

Amitai I, Geddes M, Zhu N, Keating MM, Sabloff M, Christou G, Leber B, Khalaf D, Leitch HA, St-Hilaire E, Finn N, Shamy A, Yee K, Storring J, Nevill T, Delage R, Elemary M, Banerji V, Chodirker L, Mozessohn L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Buckstein R. Amitai I, et al. Among authors: mozessohn l. Br J Haematol. 2021 Jul;194(2):319-324. doi: 10.1111/bjh.17537. Epub 2021 May 31. Br J Haematol. 2021. PMID: 34060069

3

Prognostic value of disease risk score versus gait speed in older adults with lymphoma.

Mozessohn L, Zhang L, Odejide OO, Chen R, Buckstein R, Soiffer RJ, Castillo JJ, Driver JA, Abel GA. Mozessohn L, et al. Leuk Lymphoma. 2021 Dec;62(12):2882-2889. doi: 10.1080/10428194.2021.1938029. Epub 2021 Jun 11. Leuk Lymphoma. 2021. PMID: 34114930

4

Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia.

Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. Mozessohn L, et al. JCO Oncol Pract. 2021 Apr;17(4):e517-e525. doi: 10.1200/OP.20.00446. Epub 2020 Sep 21. JCO Oncol Pract. 2021. PMID: 32956005

5

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.

Mozessohn L, Chan KK, Feld JJ, Hicks LK. Mozessohn L, et al. J Viral Hepat. 2015 Oct;22(10):842-9. doi: 10.1111/jvh.12402. Epub 2015 Mar 13. J Viral Hepat. 2015. PMID: 25765930 Review.

6

Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry.

Blunt DN, Smyth L, Nagamuthu C, Gatov E, Croxford R, Mozessohn L, Cheung MC. Blunt DN, et al. Among authors: mozessohn l. J Natl Compr Canc Netw. 2021 Mar 10;19(6):719-725. doi: 10.6004/jnccn.2020.7654. J Natl Compr Canc Netw. 2021. PMID: 33691276

7

Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada.

Bankar A, Zhao H, Iqbal J, Coxford R, Cheung MC, Mozessohn L, Earle CC, Gupta V. Bankar A, et al. Among authors: mozessohn l. Leuk Lymphoma. 2020 Aug;61(8):1908-1919. doi: 10.1080/10428194.2020.1749607. Epub 2020 Apr 23. Leuk Lymphoma. 2020. PMID: 32323602

8

Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'.

Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. Mozessohn L, et al. Leuk Lymphoma. 2020 Jun;61(6):1445-1454. doi: 10.1080/10428194.2020.1723012. Epub 2020 Feb 8. Leuk Lymphoma. 2020. PMID: 32036719

9

Polyneuropathy: a poetic diagnosis.

Pattani R, Rozenberg D, Mozessohn L, Hicks L. Pattani R, et al. Among authors: mozessohn l. BMJ Case Rep. 2012 Jul 10;2012:bcr1220115421. doi: 10.1136/bcr.12.2011.5421. BMJ Case Rep. 2012. PMID: 22783007 Free PMC article.

10

Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.

Smyth L, Blunt DN, Gatov E, Nagamuthu C, Croxford R, Mozessohn L, Cheung MC. Smyth L, et al. Among authors: mozessohn l. Br J Haematol. 2020 Nov;191(3):396-404. doi: 10.1111/bjh.16635. Epub 2020 Apr 17. Br J Haematol. 2020. PMID: 32304100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results